Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: A randomised, controlled, phase 3 trial

  1. Goss, P.E.
  2. Smith, I.E.
  3. O'Shaughnessy, J.
  4. Ejlertsen, B.
  5. Kaufmann, M.
  6. Boyle, F.
  7. Buzdar, A.U.
  8. Fumoleau, P.
  9. Gradishar, W.
  10. Martin, M.
  11. Moy, B.
  12. Piccart-Gebhart, M.
  13. Pritchard, K.I.
  14. Lindquist, D.
  15. Chavarri-Guerra, Y.
  16. Aktan, G.
  17. Rappold, E.
  18. Williams, L.S.
  19. Finkelstein, D.M.
Revista:
The Lancet Oncology

ISSN: 1470-2045 1474-5488

Any de publicació: 2013

Volum: 14

Número: 1

Pàgines: 88-96

Tipus: Article

DOI: 10.1016/S1470-2045(12)70508-9 GOOGLE SCHOLAR